

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular extravasation (GO:0045123) | 4.68031051 |
| 2 | response to peptidoglycan (GO:0032494) | 4.14041559 |
| 3 | negative regulation of leukocyte chemotaxis (GO:0002689) | 4.03353125 |
| 4 | detection of other organism (GO:0098543) | 4.01043685 |
| 5 | detection of bacterium (GO:0016045) | 3.83886663 |
| 6 | positive regulation of p38MAPK cascade (GO:1900745) | 3.79362210 |
| 7 | detection of external biotic stimulus (GO:0098581) | 3.69673179 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 3.68785463 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.65683968 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.60676687 |
| 11 | negative regulation of cell killing (GO:0031342) | 3.60676687 |
| 12 | keratan sulfate catabolic process (GO:0042340) | 3.57859765 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.51951909 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.40811252 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.40811252 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 3.40811252 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 3.40811252 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 3.40811252 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.40811252 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.31643813 |
| 21 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.30303524 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.30134935 |
| 23 | regulation of mononuclear cell migration (GO:0071675) | 3.29865713 |
| 24 | detection of biotic stimulus (GO:0009595) | 3.24250822 |
| 25 | macrophage activation (GO:0042116) | 3.24082714 |
| 26 | regulation of macrophage chemotaxis (GO:0010758) | 3.14929486 |
| 27 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.14564614 |
| 28 | germinal center formation (GO:0002467) | 3.13838002 |
| 29 | endodermal cell differentiation (GO:0035987) | 3.12845144 |
| 30 | blood vessel maturation (GO:0001955) | 3.10760113 |
| 31 | response to type I interferon (GO:0034340) | 3.10272205 |
| 32 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.09675392 |
| 33 | type I interferon signaling pathway (GO:0060337) | 3.09601778 |
| 34 | cellular response to type I interferon (GO:0071357) | 3.09601778 |
| 35 | endothelial cell morphogenesis (GO:0001886) | 3.03659012 |
| 36 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.03518046 |
| 37 | sequestering of metal ion (GO:0051238) | 3.01531254 |
| 38 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.00055448 |
| 39 | regulation of p38MAPK cascade (GO:1900744) | 2.99058157 |
| 40 | negative regulation of interleukin-8 production (GO:0032717) | 2.96588934 |
| 41 | wound healing, spreading of epidermal cells (GO:0035313) | 2.96572626 |
| 42 | skin morphogenesis (GO:0043589) | 2.96535511 |
| 43 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.93901247 |
| 44 | neutrophil mediated immunity (GO:0002446) | 2.93862507 |
| 45 | surfactant homeostasis (GO:0043129) | 2.92168914 |
| 46 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.91574688 |
| 47 | macrophage activation involved in immune response (GO:0002281) | 2.91446841 |
| 48 | protein heterotrimerization (GO:0070208) | 2.90724687 |
| 49 | response to laminar fluid shear stress (GO:0034616) | 2.89645811 |
| 50 | cell adhesion mediated by integrin (GO:0033627) | 2.87746139 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 2.86946824 |
| 52 | mannose metabolic process (GO:0006013) | 2.86034710 |
| 53 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.84802317 |
| 54 | response to progesterone (GO:0032570) | 2.81205282 |
| 55 | defense response to protozoan (GO:0042832) | 2.81020804 |
| 56 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.80901307 |
| 57 | collagen fibril organization (GO:0030199) | 2.80452860 |
| 58 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.79860283 |
| 59 | response to fungus (GO:0009620) | 2.79638736 |
| 60 | collagen metabolic process (GO:0032963) | 2.77229702 |
| 61 | detection of molecule of bacterial origin (GO:0032490) | 2.77124145 |
| 62 | regulation of gamma-delta T cell activation (GO:0046643) | 2.73516337 |
| 63 | extracellular matrix assembly (GO:0085029) | 2.72050007 |
| 64 | apoptotic cell clearance (GO:0043277) | 2.71285520 |
| 65 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.70803112 |
| 66 | response to host immune response (GO:0052572) | 2.70803112 |
| 67 | wound healing, spreading of cells (GO:0044319) | 2.70341993 |
| 68 | regulation of mast cell degranulation (GO:0043304) | 2.69876116 |
| 69 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.69781360 |
| 70 | positive regulation of osteoblast proliferation (GO:0033690) | 2.69283480 |
| 71 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.67660496 |
| 72 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.67134617 |
| 73 | response to protozoan (GO:0001562) | 2.66540039 |
| 74 | myeloid cell activation involved in immune response (GO:0002275) | 2.66202623 |
| 75 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.65703090 |
| 76 | collagen catabolic process (GO:0030574) | 2.65644965 |
| 77 | regulation of apoptotic cell clearance (GO:2000425) | 2.64674805 |
| 78 | defense response to fungus (GO:0050832) | 2.64224509 |
| 79 | complement activation, alternative pathway (GO:0006957) | 2.64052539 |
| 80 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.63562558 |
| 81 | positive regulation of type 2 immune response (GO:0002830) | 2.63069397 |
| 82 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.63013128 |
| 83 | regulation of monocyte chemotaxis (GO:0090025) | 2.62786132 |
| 84 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.60978444 |
| 85 | basement membrane organization (GO:0071711) | 2.59772775 |
| 86 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.59708756 |
| 87 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.57269959 |
| 88 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.57245068 |
| 89 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.57184309 |
| 90 | regulation of type 2 immune response (GO:0002828) | 2.56816410 |
| 91 | negative regulation of interleukin-6 production (GO:0032715) | 2.56734606 |
| 92 | reactive oxygen species biosynthetic process (GO:1903409) | 2.56421918 |
| 93 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.56047634 |
| 94 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.55469353 |
| 95 | response to host (GO:0075136) | 2.55469353 |
| 96 | response to host defenses (GO:0052200) | 2.55469353 |
| 97 | regulation of leukocyte degranulation (GO:0043300) | 2.55409482 |
| 98 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.55106469 |
| 99 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.54587245 |
| 100 | regulation of tolerance induction (GO:0002643) | 2.54031785 |
| 101 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.53913127 |
| 102 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.53913127 |
| 103 | response to muramyl dipeptide (GO:0032495) | 2.53061208 |
| 104 | regulation of chemokine biosynthetic process (GO:0045073) | 2.53023417 |
| 105 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.52764816 |
| 106 | respiratory burst (GO:0045730) | 2.52594004 |
| 107 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.52466059 |
| 108 | lymph vessel development (GO:0001945) | 2.51570584 |
| 109 | negative regulation of type 2 immune response (GO:0002829) | 2.51442872 |
| 110 | leukocyte aggregation (GO:0070486) | 2.50729428 |
| 111 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.50277976 |
| 112 | regulation of T cell tolerance induction (GO:0002664) | 2.49136659 |
| 113 | multicellular organismal catabolic process (GO:0044243) | 2.48217770 |
| 114 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.47456048 |
| 115 | pattern specification involved in kidney development (GO:0061004) | 2.47159607 |
| 116 | regulation of antigen processing and presentation (GO:0002577) | 2.46632315 |
| 117 | negative regulation of stress fiber assembly (GO:0051497) | 2.46002836 |
| 118 | response to fluid shear stress (GO:0034405) | 2.45568213 |
| 119 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.45494748 |
| 120 | neutrophil activation (GO:0042119) | 2.45408085 |
| 121 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.45353344 |
| 122 | multicellular organismal metabolic process (GO:0044236) | 2.44724859 |
| 123 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.44607156 |
| 124 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.44144422 |
| 125 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.43971925 |
| 126 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.43747233 |
| 127 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.42897903 |
| 128 | positive regulation of antigen processing and presentation (GO:0002579) | 2.41922732 |
| 129 | regulation of interferon-alpha production (GO:0032647) | 2.41752140 |
| 130 | monocyte chemotaxis (GO:0002548) | 2.41741214 |
| 131 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.41413950 |
| 132 | glial cell migration (GO:0008347) | 2.40508726 |
| 133 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.40069174 |
| 134 | macrophage differentiation (GO:0030225) | 2.39423632 |
| 135 | negative regulation of innate immune response (GO:0045824) | 2.39405216 |
| 136 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.38143090 |
| 137 | extracellular matrix disassembly (GO:0022617) | 2.37874148 |
| 138 | growth hormone receptor signaling pathway (GO:0060396) | 2.37866231 |
| 139 | barbed-end actin filament capping (GO:0051016) | 2.37378590 |
| 140 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.36912591 |
| 141 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.36585068 |
| 142 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.36180248 |
| 143 | granulocyte activation (GO:0036230) | 2.35297109 |
| 144 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.34739758 |
| 145 | myeloid leukocyte mediated immunity (GO:0002444) | 2.33562410 |
| 146 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.33211933 |
| 147 | T-helper 1 type immune response (GO:0042088) | 2.32381906 |
| 148 | positive regulation of tolerance induction (GO:0002645) | 2.31641919 |
| 149 | regulation of tumor necrosis factor production (GO:0032680) | 2.31277096 |
| 150 | myeloid dendritic cell differentiation (GO:0043011) | 2.30546026 |
| 151 | chronic inflammatory response (GO:0002544) | 2.29752194 |
| 152 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.29710147 |
| 153 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.29541584 |
| 154 | positive regulation of interferon-alpha production (GO:0032727) | 2.28486468 |
| 155 | response to interferon-alpha (GO:0035455) | 2.28468482 |
| 156 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.28421970 |
| 157 | regulation of interleukin-6 production (GO:0032675) | 2.28183813 |
| 158 | microglial cell activation (GO:0001774) | 2.27013073 |
| 159 | neutrophil chemotaxis (GO:0030593) | 2.25613123 |
| 160 | regulation of endothelial cell differentiation (GO:0045601) | 2.24486558 |
| 161 | response to increased oxygen levels (GO:0036296) | 2.22777715 |
| 162 | response to hyperoxia (GO:0055093) | 2.22777715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.77906365 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.76134516 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.79864336 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.59843306 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.40701713 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.34752056 |
| 7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.23746964 |
| 8 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.88710612 |
| 9 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.84459569 |
| 10 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.79160193 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.69804024 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.66378371 |
| 13 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.55143472 |
| 14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46914491 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.38620592 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.38358493 |
| 17 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.24049158 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23420086 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.17989726 |
| 20 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.16987993 |
| 21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.12870280 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.10806150 |
| 23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.09785997 |
| 24 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.98877572 |
| 25 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.96252387 |
| 26 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.95749894 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.95582229 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.83582025 |
| 29 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81697794 |
| 30 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81366995 |
| 31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.81358400 |
| 32 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.80879682 |
| 33 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.75993611 |
| 34 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.74643755 |
| 35 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.70028604 |
| 36 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.67057276 |
| 37 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.65199439 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.64862746 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.63814668 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63422149 |
| 41 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.61458874 |
| 42 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.55098739 |
| 43 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.55098739 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54377503 |
| 45 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.51710071 |
| 46 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.50241694 |
| 47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.49059824 |
| 48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.48707057 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48586211 |
| 50 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.46828840 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44743371 |
| 52 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43326563 |
| 53 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.41766394 |
| 54 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.37220551 |
| 55 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.34733788 |
| 56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33323468 |
| 57 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.33148326 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.30498675 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.30498675 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.30251599 |
| 61 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.29752848 |
| 62 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.29079377 |
| 63 | MAF_26560356_Chip-Seq_TH1_Human | 1.28770141 |
| 64 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28043490 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28008807 |
| 66 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27359401 |
| 67 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.27203738 |
| 68 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.26336734 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25658238 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25566107 |
| 71 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.25312223 |
| 72 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.24516904 |
| 73 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.23953335 |
| 74 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.23108869 |
| 75 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22936792 |
| 76 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.22442891 |
| 77 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21582502 |
| 78 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21208554 |
| 79 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21187571 |
| 80 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18405396 |
| 81 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17844191 |
| 82 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.17647643 |
| 83 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16316973 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16268520 |
| 85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15624226 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15599366 |
| 87 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15366468 |
| 88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.15322820 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14914701 |
| 90 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14431184 |
| 91 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12941775 |
| 92 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.12345346 |
| 93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11706935 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11411266 |
| 95 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09862405 |
| 96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09736965 |
| 97 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09580084 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09490567 |
| 99 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.09317800 |
| 100 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08967681 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07428140 |
| 102 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06344014 |
| 103 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06024260 |
| 104 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04919231 |
| 105 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04817744 |
| 106 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04602481 |
| 107 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03823417 |
| 108 | MAF_26560356_Chip-Seq_TH2_Human | 1.03019354 |
| 109 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02638016 |
| 110 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02621685 |
| 111 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02621685 |
| 112 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02485856 |
| 113 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02046051 |
| 114 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00358492 |
| 115 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00219187 |
| 116 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.00122165 |
| 117 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00105526 |
| 118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00060216 |
| 119 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99816614 |
| 120 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.98842178 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98092520 |
| 122 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97881441 |
| 123 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97235359 |
| 124 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96906812 |
| 125 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95636701 |
| 126 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95437244 |
| 127 | MYC_22102868_ChIP-Seq_BL_Human | 0.94377778 |
| 128 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94284407 |
| 129 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.94103546 |
| 130 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93937094 |
| 131 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93338998 |
| 132 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93187987 |
| 133 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.92149581 |
| 134 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.91928313 |
| 135 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90482710 |
| 136 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89753695 |
| 137 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89140293 |
| 138 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87728841 |
| 139 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.87280139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.50934171 |
| 2 | MP0003279_aneurysm | 3.52627054 |
| 3 | MP0005275_abnormal_skin_tensile | 3.50163391 |
| 4 | MP0003724_increased_susceptibility_to | 3.27870292 |
| 5 | MP0003303_peritoneal_inflammation | 3.23688393 |
| 6 | MP0005503_abnormal_tendon_morphology | 3.22989236 |
| 7 | MP0001958_emphysema | 3.20244433 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.59166852 |
| 9 | MP0000343_altered_response_to | 2.48929019 |
| 10 | MP0003436_decreased_susceptibility_to | 2.45286940 |
| 11 | MP0009278_abnormal_bone_marrow | 2.27289934 |
| 12 | MP0005023_abnormal_wound_healing | 2.13288547 |
| 13 | MP0005257_abnormal_intraocular_pressure | 2.08434949 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.02793580 |
| 15 | MP0009785_altered_susceptibility_to | 2.01841457 |
| 16 | MP0001533_abnormal_skeleton_physiology | 2.01095870 |
| 17 | MP0004272_abnormal_basement_membrane | 1.95295985 |
| 18 | MP0001879_abnormal_lymphatic_vessel | 1.87504243 |
| 19 | MP0009384_cardiac_valve_regurgitation | 1.85275671 |
| 20 | MP0003828_pulmonary_edema | 1.80478371 |
| 21 | MP0005164_abnormal_response_to | 1.72750579 |
| 22 | MP0010368_abnormal_lymphatic_system | 1.72364925 |
| 23 | MP0002419_abnormal_innate_immunity | 1.71287465 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.71217653 |
| 25 | MP0002060_abnormal_skin_morphology | 1.67502130 |
| 26 | MP0009840_abnormal_foam_cell | 1.66727122 |
| 27 | MP0002933_joint_inflammation | 1.66423562 |
| 28 | MP0002295_abnormal_pulmonary_circulatio | 1.65258178 |
| 29 | MP0005390_skeleton_phenotype | 1.64153511 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.63787231 |
| 31 | MP0005671_abnormal_response_to | 1.57974632 |
| 32 | MP0005451_abnormal_body_composition | 1.54433494 |
| 33 | MP0006054_spinal_hemorrhage | 1.53517217 |
| 34 | MP0003448_altered_tumor_morphology | 1.53005503 |
| 35 | MP0005167_abnormal_blood-brain_barrier | 1.51977621 |
| 36 | MP0005508_abnormal_skeleton_morphology | 1.49216501 |
| 37 | MP0008260_abnormal_autophagy | 1.47811203 |
| 38 | MP0000750_abnormal_muscle_regeneration | 1.46806771 |
| 39 | MP0009764_decreased_sensitivity_to | 1.45508520 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.44171806 |
| 41 | MP0000858_altered_metastatic_potential | 1.41758888 |
| 42 | MP0003091_abnormal_cell_migration | 1.41642095 |
| 43 | MP0000767_abnormal_smooth_muscle | 1.40209062 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.38346703 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.36104915 |
| 46 | MP0003075_altered_response_to | 1.35364479 |
| 47 | MP0010352_gastrointestinal_tract_polyps | 1.33168119 |
| 48 | MP0003690_abnormal_glial_cell | 1.32788439 |
| 49 | MP0004883_abnormal_blood_vessel | 1.29994851 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.26431544 |
| 51 | MP0005025_abnormal_response_to | 1.26067101 |
| 52 | MP0001853_heart_inflammation | 1.20840957 |
| 53 | MP0000249_abnormal_blood_vessel | 1.20755963 |
| 54 | MP0000604_amyloidosis | 1.18119441 |
| 55 | MP0001851_eye_inflammation | 1.17562482 |
| 56 | MP0002405_respiratory_system_inflammati | 1.14229405 |
| 57 | MP0004858_abnormal_nervous_system | 1.12199486 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.11688110 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.11688110 |
| 60 | MP0002132_abnormal_respiratory_system | 1.10442473 |
| 61 | MP0003011_delayed_dark_adaptation | 1.07495546 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.07152390 |
| 63 | MP0002166_altered_tumor_susceptibility | 1.05832929 |
| 64 | MP0005595_abnormal_vascular_smooth | 1.05307495 |
| 65 | MP0004510_myositis | 1.04924459 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.04877567 |
| 67 | MP0005388_respiratory_system_phenotype | 1.04200365 |
| 68 | MP0002133_abnormal_respiratory_system | 1.04200365 |
| 69 | MP0000733_abnormal_muscle_development | 1.02709849 |
| 70 | MP0000716_abnormal_immune_system | 1.02150779 |
| 71 | MP0001845_abnormal_inflammatory_respons | 1.01486485 |
| 72 | MP0005058_abnormal_lysosome_morphology | 1.01380803 |
| 73 | MP0001542_abnormal_bone_strength | 1.00763289 |
| 74 | MP0001790_abnormal_immune_system | 1.00073251 |
| 75 | MP0005387_immune_system_phenotype | 1.00073251 |
| 76 | MP0005165_increased_susceptibility_to | 0.99332897 |
| 77 | MP0005166_decreased_susceptibility_to | 0.99164052 |
| 78 | MP0003795_abnormal_bone_structure | 0.98827198 |
| 79 | MP0001835_abnormal_antigen_presentation | 0.98218963 |
| 80 | MP0002452_abnormal_antigen_presenting | 0.96994555 |
| 81 | MP0005197_abnormal_uvea_morphology | 0.96200773 |
| 82 | MP0002332_abnormal_exercise_endurance | 0.95582514 |
| 83 | MP0004947_skin_inflammation | 0.95538044 |
| 84 | MP0002896_abnormal_bone_mineralization | 0.95254085 |
| 85 | MP0009379_abnormal_foot_pigmentation | 0.93830878 |
| 86 | MP0000685_abnormal_immune_system | 0.93358222 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 0.92957267 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 0.92701529 |
| 89 | MP0003191_abnormal_cellular_cholesterol | 0.92679105 |
| 90 | MP0010155_abnormal_intestine_physiology | 0.91469546 |
| 91 | MP0004808_abnormal_hematopoietic_stem | 0.90799009 |
| 92 | MP0002108_abnormal_muscle_morphology | 0.90254379 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 0.89022575 |
| 94 | MP0009763_increased_sensitivity_to | 0.87751874 |
| 95 | MP0003763_abnormal_thymus_physiology | 0.87615861 |
| 96 | MP0008004_abnormal_stomach_pH | 0.87146627 |
| 97 | * MP0005076_abnormal_cell_differentiation | 0.83113532 |
| 98 | MP0002006_tumorigenesis | 0.82099240 |
| 99 | MP0003866_abnormal_defecation | 0.82087202 |
| 100 | MP0008469_abnormal_protein_level | 0.82039523 |
| 101 | MP0002723_abnormal_immune_serum | 0.81517542 |
| 102 | MP0003045_fibrosis | 0.81449986 |
| 103 | MP0003183_abnormal_peptide_metabolism | 0.81035934 |
| 104 | MP0002398_abnormal_bone_marrow | 0.80167558 |
| 105 | MP0002139_abnormal_hepatobiliary_system | 0.80063346 |
| 106 | MP0000465_gastrointestinal_hemorrhage | 0.80037792 |
| 107 | MP0006082_CNS_inflammation | 0.79344217 |
| 108 | MP0001243_abnormal_dermal_layer | 0.79129119 |
| 109 | MP0001663_abnormal_digestive_system | 0.79087717 |
| 110 | MP0001175_abnormal_lung_morphology | 0.78508202 |
| 111 | MP0000163_abnormal_cartilage_morphology | 0.76019796 |
| 112 | MP0001614_abnormal_blood_vessel | 0.75295846 |
| 113 | MP0005666_abnormal_adipose_tissue | 0.75025458 |
| 114 | MP0002420_abnormal_adaptive_immunity | 0.74291052 |
| 115 | MP0002254_reproductive_system_inflammat | 0.74273237 |
| 116 | MP0001819_abnormal_immune_cell | 0.74093229 |
| 117 | MP0002429_abnormal_blood_cell | 0.73098580 |
| 118 | MP0008874_decreased_physiological_sensi | 0.71207709 |
| 119 | MP0003186_abnormal_redox_activity | 0.70525036 |
| 120 | MP0001800_abnormal_humoral_immune | 0.70364387 |
| 121 | MP0002113_abnormal_skeleton_development | 0.70200114 |
| 122 | MP0002722_abnormal_immune_system | 0.69729601 |
| 123 | MP0005310_abnormal_salivary_gland | 0.69026707 |
| 124 | MP0005464_abnormal_platelet_physiology | 0.68906915 |
| 125 | MP0002128_abnormal_blood_circulation | 0.68052479 |
| 126 | MP0003329_amyloid_beta_deposits | 0.67790762 |
| 127 | MP0005375_adipose_tissue_phenotype | 0.66305373 |
| 128 | MP0003879_abnormal_hair_cell | 0.65599939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 5.72211923 |
| 2 | Premature rupture of membranes (HP:0001788) | 5.57989940 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.28412011 |
| 4 | Ankle contracture (HP:0006466) | 3.94926969 |
| 5 | Optic neuritis (HP:0100653) | 3.87789358 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 3.87789358 |
| 7 | Peritonitis (HP:0002586) | 3.86200166 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.71616741 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.71616741 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.71616741 |
| 11 | Complement deficiency (HP:0004431) | 3.69901329 |
| 12 | Vertebral compression fractures (HP:0002953) | 3.59986373 |
| 13 | Cervical subluxation (HP:0003308) | 3.57997905 |
| 14 | Soft skin (HP:0000977) | 3.55477824 |
| 15 | Abnormality of complement system (HP:0005339) | 3.55288996 |
| 16 | Cerebral aneurysm (HP:0004944) | 3.50865440 |
| 17 | Recurrent abscess formation (HP:0002722) | 3.49907014 |
| 18 | Shallow orbits (HP:0000586) | 3.48607207 |
| 19 | Broad metatarsal (HP:0001783) | 3.37076043 |
| 20 | Hematochezia (HP:0002573) | 3.31500290 |
| 21 | Aortic aneurysm (HP:0004942) | 3.24270233 |
| 22 | Aortic dissection (HP:0002647) | 3.24108627 |
| 23 | Atrophic scars (HP:0001075) | 3.22417918 |
| 24 | Vascular tortuosity (HP:0004948) | 3.20757423 |
| 25 | Interstitial pulmonary disease (HP:0006530) | 3.15561017 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.12659508 |
| 27 | Increased IgE level (HP:0003212) | 3.06094002 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 3.04072102 |
| 29 | Dilatation of the ascending aorta (HP:0005111) | 2.94107761 |
| 30 | Keratoconjunctivitis sicca (HP:0001097) | 2.93885467 |
| 31 | Wrist flexion contracture (HP:0001239) | 2.92005182 |
| 32 | Increased connective tissue (HP:0009025) | 2.91899026 |
| 33 | Stomatitis (HP:0010280) | 2.88812795 |
| 34 | Spontaneous hematomas (HP:0007420) | 2.88320383 |
| 35 | Axonal loss (HP:0003447) | 2.87434088 |
| 36 | Fragile skin (HP:0001030) | 2.82878269 |
| 37 | Spinal rigidity (HP:0003306) | 2.82552270 |
| 38 | Arterial tortuosity (HP:0005116) | 2.78900988 |
| 39 | Osteolytic defects of the hand bones (HP:0009699) | 2.71171273 |
| 40 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.71171273 |
| 41 | Keratoconjunctivitis (HP:0001096) | 2.62867411 |
| 42 | Wormian bones (HP:0002645) | 2.60934869 |
| 43 | Dysostosis multiplex (HP:0000943) | 2.59912235 |
| 44 | Gastrointestinal infarctions (HP:0005244) | 2.56973383 |
| 45 | Bladder diverticulum (HP:0000015) | 2.54679339 |
| 46 | Purpura (HP:0000979) | 2.53939330 |
| 47 | Follicular hyperkeratosis (HP:0007502) | 2.52979534 |
| 48 | Loss of speech (HP:0002371) | 2.52348478 |
| 49 | Abnormality of macrophages (HP:0004311) | 2.51636439 |
| 50 | Meningitis (HP:0001287) | 2.50826096 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.49028078 |
| 52 | Hemoptysis (HP:0002105) | 2.48680357 |
| 53 | Recurrent skin infections (HP:0001581) | 2.47755079 |
| 54 | Myositis (HP:0100614) | 2.46084290 |
| 55 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.42828507 |
| 56 | Mucopolysacchariduria (HP:0008155) | 2.42828507 |
| 57 | Mitral valve prolapse (HP:0001634) | 2.41430653 |
| 58 | Vasculitis (HP:0002633) | 2.39697345 |
| 59 | Recurrent fungal infections (HP:0002841) | 2.38864559 |
| 60 | Biconcave vertebral bodies (HP:0004586) | 2.37200805 |
| 61 | Malnutrition (HP:0004395) | 2.36623255 |
| 62 | Systemic lupus erythematosus (HP:0002725) | 2.35117567 |
| 63 | Type 1 muscle fiber predominance (HP:0003803) | 2.31627837 |
| 64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.30714771 |
| 65 | Gingivitis (HP:0000230) | 2.29972657 |
| 66 | Nonimmune hydrops fetalis (HP:0001790) | 2.28783903 |
| 67 | Blue sclerae (HP:0000592) | 2.28690869 |
| 68 | Vacuolated lymphocytes (HP:0001922) | 2.25387204 |
| 69 | Increased serum ferritin (HP:0003281) | 2.24153779 |
| 70 | Myocardial infarction (HP:0001658) | 2.24052803 |
| 71 | Orchitis (HP:0100796) | 2.23236867 |
| 72 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.21023019 |
| 73 | Pulmonary embolism (HP:0002204) | 2.18647393 |
| 74 | Slender build (HP:0001533) | 2.18171755 |
| 75 | Hyperextensible skin (HP:0000974) | 2.17182299 |
| 76 | Asymmetric septal hypertrophy (HP:0001670) | 2.16546170 |
| 77 | Cellulitis (HP:0100658) | 2.15719887 |
| 78 | Pulmonary artery stenosis (HP:0004415) | 2.15338562 |
| 79 | Generalized amyotrophy (HP:0003700) | 2.15252249 |
| 80 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.14969563 |
| 81 | Episodic fever (HP:0001954) | 2.14902170 |
| 82 | Joint stiffness (HP:0001387) | 2.14594136 |
| 83 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.12662355 |
| 84 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.12662355 |
| 85 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.12662355 |
| 86 | Gangrene (HP:0100758) | 2.10483407 |
| 87 | Aneurysm (HP:0002617) | 2.09704206 |
| 88 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07862685 |
| 89 | Arterial thrombosis (HP:0004420) | 2.05255173 |
| 90 | Gingival bleeding (HP:0000225) | 2.03578429 |
| 91 | Spondylolisthesis (HP:0003302) | 2.01718007 |
| 92 | Mediastinal lymphadenopathy (HP:0100721) | 2.01664302 |
| 93 | Epistaxis (HP:0000421) | 2.01406687 |
| 94 | Abnormality of the pleura (HP:0002103) | 1.99684987 |
| 95 | Genu recurvatum (HP:0002816) | 1.99433987 |
| 96 | Broad ribs (HP:0000885) | 1.98184793 |
| 97 | Hypergammaglobulinemia (HP:0010702) | 1.97627287 |
| 98 | Prolonged bleeding time (HP:0003010) | 1.96688923 |
| 99 | Chest pain (HP:0100749) | 1.96039628 |
| 100 | Colitis (HP:0002583) | 1.95853372 |
| 101 | Neurofibrillary tangles (HP:0002185) | 1.94905722 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 1.94688470 |
| 103 | Acne (HP:0001061) | 1.94673276 |
| 104 | Distal lower limb muscle weakness (HP:0009053) | 1.94422172 |
| 105 | Muscle fiber splitting (HP:0003555) | 1.94166388 |
| 106 | Camptodactyly of toe (HP:0001836) | 1.93686861 |
| 107 | Encephalitis (HP:0002383) | 1.93233421 |
| 108 | Elbow flexion contracture (HP:0002987) | 1.91087707 |
| 109 | Short hallux (HP:0010109) | 1.91063503 |
| 110 | Increased density of long bones (HP:0006392) | 1.89012200 |
| 111 | Abnormality of the peritoneum (HP:0002585) | 1.86965480 |
| 112 | Flexion contracture of toe (HP:0005830) | 1.86478885 |
| 113 | Joint contractures involving the joints of the feet (HP:0100492) | 1.86478885 |
| 114 | Hemorrhage of the eye (HP:0011885) | 1.86424226 |
| 115 | Thoracolumbar scoliosis (HP:0002944) | 1.85831644 |
| 116 | Neonatal short-limb short stature (HP:0008921) | 1.85763497 |
| 117 | Amyloidosis (HP:0011034) | 1.85673045 |
| 118 | Rectal prolapse (HP:0002035) | 1.84828023 |
| 119 | Aortic valve stenosis (HP:0001650) | 1.84660614 |
| 120 | Beaking of vertebral bodies (HP:0004568) | 1.84123620 |
| 121 | Petechiae (HP:0000967) | 1.82781648 |
| 122 | Short nail (HP:0001799) | 1.81973491 |
| 123 | Abnormality of the acetabulum (HP:0003170) | 1.80993132 |
| 124 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.80824399 |
| 125 | Abnormality of the odontoid process (HP:0003310) | 1.80361828 |
| 126 | Polycythemia (HP:0001901) | 1.80349612 |
| 127 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.80046510 |
| 128 | Osteomyelitis (HP:0002754) | 1.79455816 |
| 129 | Mitral regurgitation (HP:0001653) | 1.78984402 |
| 130 | Polygenic inheritance (HP:0010982) | 1.78704311 |
| 131 | Emphysema (HP:0002097) | 1.77433108 |
| 132 | Ovoid vertebral bodies (HP:0003300) | 1.77225547 |
| 133 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.76489835 |
| 134 | Nephritis (HP:0000123) | 1.75991088 |
| 135 | Leukocytosis (HP:0001974) | 1.75561747 |
| 136 | Chondrocalcinosis (HP:0000934) | 1.75306288 |
| 137 | Thick nail (HP:0001805) | 1.73734270 |
| 138 | Nasal polyposis (HP:0100582) | 1.73344835 |
| 139 | Nuclear cataract (HP:0100018) | 1.73217115 |
| 140 | Inflammation of the large intestine (HP:0002037) | 1.73149938 |
| 141 | Overgrowth (HP:0001548) | 1.72965772 |
| 142 | Chronic obstructive pulmonary disease (HP:0006510) | 1.72688835 |
| 143 | Obstructive lung disease (HP:0006536) | 1.72688835 |
| 144 | Anorexia (HP:0002039) | 1.72340247 |
| 145 | Abnormality of the nasal mucosa (HP:0000433) | 1.72162426 |
| 146 | Esophageal varix (HP:0002040) | 1.72161199 |
| 147 | Vertigo (HP:0002321) | 1.71732546 |
| 148 | Abnormal delivery (HP:0001787) | 1.71112165 |
| 149 | Increased variability in muscle fiber diameter (HP:0003557) | 1.70940016 |
| 150 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.70928450 |
| 151 | Abnormality of the pericardium (HP:0001697) | 1.68722211 |
| 152 | Coxa vara (HP:0002812) | 1.68463925 |
| 153 | Abnormality of the lumbar spine (HP:0100712) | 1.66226741 |
| 154 | Increased cerebral lipofuscin (HP:0011813) | 1.65901490 |
| 155 | Urticaria (HP:0001025) | 1.65477043 |
| 156 | Glomerulonephritis (HP:0000099) | 1.64942393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.60054374 |
| 2 | TGFBR2 | 3.05525812 |
| 3 | EPHB1 | 2.80800836 |
| 4 | MAP3K3 | 2.70578707 |
| 5 | TRIB3 | 2.60909402 |
| 6 | PRPF4B | 2.42793758 |
| 7 | EPHA3 | 2.27616418 |
| 8 | RIPK1 | 2.14893230 |
| 9 | BLK | 2.12016431 |
| 10 | IRAK3 | 2.03116374 |
| 11 | MAP4K1 | 2.01522771 |
| 12 | MAPK15 | 1.90520965 |
| 13 | TBK1 | 1.87228548 |
| 14 | IRAK4 | 1.85694676 |
| 15 | PIM2 | 1.84504749 |
| 16 | TIE1 | 1.83368852 |
| 17 | KDR | 1.76460163 |
| 18 | TTN | 1.73575781 |
| 19 | MAP2K3 | 1.64043458 |
| 20 | STK10 | 1.63960326 |
| 21 | MAP2K2 | 1.62578884 |
| 22 | CSK | 1.59156612 |
| 23 | MOS | 1.58822742 |
| 24 | TYK2 | 1.57919333 |
| 25 | TAOK2 | 1.57598632 |
| 26 | RPS6KA4 | 1.54992170 |
| 27 | LRRK2 | 1.53481033 |
| 28 | MAP3K14 | 1.52218171 |
| 29 | TEC | 1.49043707 |
| 30 | NME2 | 1.47627023 |
| 31 | MAP3K6 | 1.45429035 |
| 32 | TRPM7 | 1.43385434 |
| 33 | CDC42BPA | 1.35257011 |
| 34 | DDR2 | 1.34205559 |
| 35 | EPHB2 | 1.31530293 |
| 36 | GRK7 | 1.30014508 |
| 37 | PTK6 | 1.29318651 |
| 38 | NLK | 1.28611314 |
| 39 | PAK4 | 1.27708980 |
| 40 | FGFR4 | 1.27570456 |
| 41 | TNK2 | 1.26259522 |
| 42 | RIPK4 | 1.19329551 |
| 43 | PDGFRA | 1.19047761 |
| 44 | KIT | 1.16817334 |
| 45 | PTK2 | 1.16576870 |
| 46 | GRK6 | 1.16436734 |
| 47 | NEK9 | 1.15944888 |
| 48 | TESK1 | 1.14455656 |
| 49 | IKBKB | 1.14293977 |
| 50 | MARK2 | 1.12357629 |
| 51 | BMX | 1.11972977 |
| 52 | FGR | 1.10161021 |
| 53 | JAK1 | 1.07518650 |
| 54 | IKBKE | 1.06910538 |
| 55 | PKN2 | 1.06432359 |
| 56 | PRKD2 | 1.04366766 |
| 57 | PDPK1 | 1.01203314 |
| 58 | MAP3K13 | 1.00379278 |
| 59 | PRKG2 | 0.99139346 |
| 60 | PAK2 | 0.97237477 |
| 61 | MAPK7 | 0.96911207 |
| 62 | IRAK1 | 0.96606863 |
| 63 | MST1R | 0.96539598 |
| 64 | EPHA2 | 0.94854382 |
| 65 | BTK | 0.94674307 |
| 66 | SYK | 0.93534231 |
| 67 | FER | 0.91167844 |
| 68 | TESK2 | 0.90830011 |
| 69 | MST4 | 0.89929622 |
| 70 | DMPK | 0.89164866 |
| 71 | ZAP70 | 0.88618647 |
| 72 | ILK | 0.87855621 |
| 73 | ABL2 | 0.87457938 |
| 74 | CSF1R | 0.84493876 |
| 75 | LATS2 | 0.83317438 |
| 76 | HCK | 0.82229336 |
| 77 | LYN | 0.81424922 |
| 78 | GSK3A | 0.80453902 |
| 79 | PTK2B | 0.80440484 |
| 80 | IRAK2 | 0.80226075 |
| 81 | MAPK12 | 0.79104325 |
| 82 | HIPK2 | 0.78638064 |
| 83 | JAK3 | 0.76299222 |
| 84 | CLK1 | 0.74830878 |
| 85 | PDK1 | 0.73800266 |
| 86 | SMG1 | 0.73002269 |
| 87 | MAP3K7 | 0.71623675 |
| 88 | FES | 0.71137917 |
| 89 | PIK3CG | 0.70238576 |
| 90 | MAP3K1 | 0.69967469 |
| 91 | LCK | 0.69138620 |
| 92 | SIK1 | 0.67133541 |
| 93 | MYLK | 0.67090699 |
| 94 | CHUK | 0.67068595 |
| 95 | BMPR2 | 0.65812071 |
| 96 | MAPKAPK2 | 0.64927645 |
| 97 | JAK2 | 0.64176771 |
| 98 | STK38 | 0.64101244 |
| 99 | RPS6KA6 | 0.62551954 |
| 100 | TLK1 | 0.61691678 |
| 101 | RPS6KA2 | 0.61487650 |
| 102 | PIM1 | 0.61310080 |
| 103 | MAPK4 | 0.60678275 |
| 104 | TGFBR1 | 0.60499011 |
| 105 | RPS6KL1 | 0.58249864 |
| 106 | RPS6KC1 | 0.58249864 |
| 107 | MAPKAPK3 | 0.58239830 |
| 108 | KSR2 | 0.58091730 |
| 109 | TAOK1 | 0.57503947 |
| 110 | MARK3 | 0.57170332 |
| 111 | MATK | 0.57075850 |
| 112 | TXK | 0.56185282 |
| 113 | MAP3K11 | 0.55413608 |
| 114 | MAP2K6 | 0.55158360 |
| 115 | ITK | 0.53040608 |
| 116 | ABL1 | 0.52729430 |
| 117 | MAP3K2 | 0.52312801 |
| 118 | FLT3 | 0.51647213 |
| 119 | FGFR3 | 0.51625949 |
| 120 | PDGFRB | 0.49681339 |
| 121 | CAMK1D | 0.48173837 |
| 122 | MAP3K5 | 0.46218962 |
| 123 | ICK | 0.46159023 |
| 124 | TAOK3 | 0.45450077 |
| 125 | EIF2AK2 | 0.45244944 |
| 126 | FYN | 0.43241666 |
| 127 | SGK3 | 0.43059891 |
| 128 | PRKD1 | 0.42925824 |
| 129 | MET | 0.42389130 |
| 130 | RET | 0.41240897 |
| 131 | PRKAA2 | 0.39612124 |
| 132 | CDK6 | 0.39132172 |
| 133 | ROCK1 | 0.38296965 |
| 134 | SCYL2 | 0.37161479 |
| 135 | PRKCD | 0.35752187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Malaria_Homo sapiens_hsa05144 | 3.28571661 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.71427526 |
| 3 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.20835050 |
| 4 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.18605920 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.13116594 |
| 6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.12997544 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.12911870 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.08471881 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.04821815 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 1.91858576 |
| 11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.86858089 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.80449814 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.80057280 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.79900572 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.76798730 |
| 16 | Amoebiasis_Homo sapiens_hsa05146 | 1.73027239 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.71141849 |
| 18 | Focal adhesion_Homo sapiens_hsa04510 | 1.68983897 |
| 19 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.63604094 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57246393 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.55197619 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53335019 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.49834772 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.48559686 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45597621 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.44419025 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.43439629 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.39551386 |
| 29 | Bladder cancer_Homo sapiens_hsa05219 | 1.38864965 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.37986271 |
| 31 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.34873220 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33266307 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.27902164 |
| 34 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.26861460 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19959170 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18283862 |
| 37 | Adherens junction_Homo sapiens_hsa04520 | 1.17943305 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.15239836 |
| 39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.14300639 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.13731067 |
| 41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09324571 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.05589784 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.04245146 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03211285 |
| 45 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01801943 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00016113 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99732225 |
| 48 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.99623352 |
| 49 | Measles_Homo sapiens_hsa05162 | 0.99172761 |
| 50 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.99113583 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.98750292 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98374044 |
| 53 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.95928580 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95221270 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94180169 |
| 56 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.93454691 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.91408151 |
| 58 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.90724369 |
| 59 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87724761 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87490266 |
| 61 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86873549 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86759577 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85434409 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84976622 |
| 65 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84423522 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84019570 |
| 67 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82322170 |
| 68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80279453 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80233869 |
| 70 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79751474 |
| 71 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.79272617 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.79120344 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.79107268 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.77988248 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77529070 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.77235193 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76259299 |
| 78 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.74678456 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.72629064 |
| 80 | Pathways in cancer_Homo sapiens_hsa05200 | 0.72580778 |
| 81 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.71407824 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.71268480 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71004613 |
| 84 | Melanoma_Homo sapiens_hsa05218 | 0.70858595 |
| 85 | Ribosome_Homo sapiens_hsa03010 | 0.67471006 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67134935 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64715329 |
| 88 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.64150664 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63972639 |
| 90 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.63936618 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62750172 |
| 92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61822513 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61759636 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.61568057 |
| 95 | Asthma_Homo sapiens_hsa05310 | 0.61463900 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60866252 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60198663 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60062554 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59212764 |
| 100 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.57960973 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.55545621 |
| 102 | Protein export_Homo sapiens_hsa03060 | 0.53654408 |
| 103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52647059 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52366423 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51982480 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51565557 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50972091 |
| 108 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50749530 |
| 109 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.47615482 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47586234 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47491524 |
| 112 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47252399 |
| 113 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46817101 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46742319 |
| 115 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45995930 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44921661 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44579678 |
| 118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44324955 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43901968 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43481493 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43280642 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41867702 |
| 123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41358673 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38754432 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38407930 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38250934 |
| 127 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37887671 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36784597 |
| 129 | Histidine metabolism_Homo sapiens_hsa00340 | 0.35826750 |
| 130 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35270252 |

